CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35 enrolled
Drug / intervention
Near Infrared Spectroscopydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03384173
NCT03384173N/ACompleted

Use of NIRS to Detect Acute Kidney Injury in Preterm Infants

University of Wisconsin, Madison·observational·Posted Dec 27, 2017·Updated Nov 29, 2022

In Brief

An observational study evaluating Near Infrared Spectroscopy for Acute Kidney Injury and Premature Infant. Completed, enrolled 35 participants across 1 site.

Detailed Summary

This study will examine the relationship of oxygen levels, using Near-infrared spectroscopy (NIRS) monitoring, and kidney injury in infants born prematurely. NIRS is a skin sensor which detects the amount of oxygen going to different organs, most often used to monitor the brain and kidney.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 27, 2017
Enrollment StartApr 25, 2018
Primary CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.5 years ago

Interventions

Near Infrared Spectroscopydevice

Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.